查看完整行情页>>

|

货币单位:美元(USD)

Senseonics Holdings, Inc. (sens)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Rick Sullivan Rick Sullivan occupies the position of Chief Financial Officer, Secretary & Treasurer for Senseonics Holdings, Inc. and Chief Financial Officer at Senseonics, Inc. (a subsidiary of Senseonics Holdings, Inc.). He is also Principal at Hike Financial LLC. In his past career he held the position of Chief Financial Officer of RoosterBio, Inc. He received an MBA from Robert H. Smith School of Business and an undergraduate degree from Salisbury State University.
Abhi Chavan Currently, Abhi Chavan is Vice President-Engineering, Research & Development at Senseonics Holdings, Inc. and Vice President-Engineering, Research & Development at Senseonics, Inc. (a subsidiary of Senseonics Holdings, Inc.). Dr. Chavan is also Vice President-Engineering, Research & Development at Senseonics, Inc., Senior Member at Institute of Electrical & Electronics Engineers and Senior Member at IEEE Engineering in Medicine & Biology Society. In his past career he occupied the position of Vice President-Research & Product Development at Medtronic Monitoring, Inc. Dr. Chavan received a doctorate from the University of Michigan, a graduate degree from Syracuse University and an undergraduate degree from the University of Baroda.
Mukul Kumar Jain Currently, Mukul Kumar Jain occupies the position of Chief Operating Officer of Senseonics Holdings, Inc. and Chief Operating Officer at Senseonics, Inc. (a subsidiary of Senseonics Holdings, Inc.). Dr. Jain is also on the board of Lambent Technologies Pvt Ltd., Sequelone Solutions Pvt Ltd. and Mehai Technology Ltd. and Chief Operating Officer of Senseonics, Inc. Dr. Jain previously held the position of Principal at HCL Technologies Ltd., Chief Operating Officer for GlobalLogic, Inc. and Senior Program Manager at Medtronic, Inc. Mukul Kumar Jain received an undergraduate degree from Indian Institute of Technology Kanpur, a doctorate from the University of South Carolina and an MBA from The Curtis L. Carlson School of Management.
Katherine S. Tweden Founder of EnteroMedics, Inc., Katherine S. Tweden presently is Vice President-Clinical Sciences at Senseonics Holdings, Inc. and Vice President-Clinical Sciences at Senseonics, Inc. (a subsidiary of Senseonics Holdings, Inc.). She is also Vice President-Clinical Sciences at Senseonics, Inc. In the past Dr. Tweden was Vice President-Research at Heartstent Corp., Vice President at Venturi Group LLC, Senior Research Scientist at St. Jude Medical LLC and Senior Vice President-Research at EnteroMedics, Inc. Dr. Tweden received a doctorate and a graduate degree from Iowa State University and an undergraduate degree from Gustavus Adolphus College.
Francine R. Kaufman Presently, Francine R. Kaufman occupies the position of Chief Executive Officer of Clinical Products LLC, Director & Chief Medical Officer at Senseonics Holdings, Inc., Director & Chief Medical Officer at Senseonics, Inc. (a subsidiary of Senseonics Holdings, Inc.) and Partner and Advisor at JDRF T1D Fund. She is also Professor at the University of Southern California, Member of American Academy of Pediatrics and Professor at Keck School of Medicine of USC. In her past career Francine R. Kaufman occupied the position of Chairman for National Diabetes Education Program, Vice President-Global Medical Affairs & CMO at Medtronic MiniMed, Inc., Chairman for National Academy of Medicine (United States), President of American Diabetes Association and Head-Centre for Endocrinology at Children's Hospital Los Angeles. She received an undergraduate degree from Northwestern University, an undergraduate degree from Rosalind Franklin University of Medicine & Science and a doctorate from Chicago Medical School.
Stephen P. DeFalco Stephen P. DeFalco is a businessperson who has been the head of 10 different companies and presently occupies the position of Chairman & Chief Executive Officer for Creation Technologies LP, President at Creation Technologies Illinois, Inc. (a subsidiary of Creation Technologies LP), Chairman for Senseonics Holdings, Inc. and Chairman & Chief Executive Officer for Creation Technologies, Inc. In the past he was President, Chief Executive Officer & Director at Crane & Co., Inc., Senior Vice President of Revvity, Inc. and President for Perkinelmer Instruments LLC (a subsidiary of Revvity, Inc.), Partner at McKinsey & Co., Inc., Chairman of Senseonics, Inc., Chairman & Chief Executive Officer at PathoGenetix, Inc., President & Chief Executive Officer for Nordion (Canada), Inc., Principal at United Technologies Corp. and Partner at Goldberg Lindsay & Co. LLC. He received an undergraduate degree from Massachusetts Institute of Technology, a graduate degree from Syracuse University and an MBA from MIT Sloan School of Management.
Timothy T. Goodnow Timothy T. Goodnow occupies the position of President, Chief Executive Officer & Director at Senseonics Holdings, Inc. In the past Dr. Goodnow was Principal at Verax Biomedical, Inc., President, Chief Executive Officer & Director at Senseonics, Inc., Vice President-Research & Development at TheraSense, Inc., Vice President-Technical Operations at Abbott Diabetes Care, Inc., Principal at Baxter Healthcare Corp. and Principal at Dade Behring, Inc. Dr. Goodnow received a doctorate and an undergraduate degree from the University of Miami.
Douglas A. Roeder Currently, Douglas A. Roeder holds the position of Managing Partner at Delphi Ventures, Inc. He is also on the board of Ivantis, Inc. and Senseonics Holdings, Inc. In his past career Mr. Roeder held the position of Associate of Alex. Brown & Sons, Inc. and Principal at Putnam Associates LLC. He received an undergraduate degree from Dartmouth College.
Sharon D. Larkin Sharon D. Larkin is on the board of Senseonics, Inc. and Senseonics Holdings, Inc. She previously occupied the position of Divisional VP-HR & Medical Devices Group at Abbott Laboratories and Senior VP-Human Resources & Administration at Assertio Therapeutics, Inc. Sharon D. Larkin received an undergraduate degree from Georgia Institute of Technology.
Steven V. Edelman Steven V. Edelman founded Taking Control of Your Diabetes. He is on the board of Senseonics, Inc., Taking Control of Your Diabetes and Senseonics Holdings, Inc. and Professor at the University of California San Diego, Director-Diabetes Care Clinic at VA Medical Center (District of Columbia) and Professor at Veterans Affairs Healthcare System of San Diego. Steven V. Edelman received an undergraduate degree and a graduate degree from the University of California, Los Angeles and a doctorate from the University of California, Davis.
Anthony R. Raab Currently, Anthony R. Raab is Senior Investment Research Analyst at Masters Capital Management LLC. Mr. Raab is also on the board of Senseonics, Inc. and Senseonics Holdings, Inc. In the past Mr. Raab occupied the position of Partner & Portfolio Manager at Perimeter Capital Partners LLC and Analyst at TCW Asset Management Co. LLC. He received an undergraduate degree from Duke University.
Douglas S. Prince Douglas S. Prince is on the board of Creation Technologies LP and Senseonics Holdings, Inc. In his past career Mr. Prince occupied the position of Vice President-Finance of Revvity, Inc., Chief Financial Officer & Treasurer of Crane & Co., Inc., Chief Financial Officer at Northern Power Systems Corp., Chief Financial Officer of Nordion (Canada), Inc., Principal at General Electric Capital Corp. and Principal at Aeroquip-Vickers, Inc. Douglas S. Prince received an undergraduate degree from the University of Kentucky.
Edward J. Fiorentino Founder of Actient Pharmaceuticals LLC and TerSera Therapeutics LLC, Edward J. Fiorentino currently holds the position of Executive Chairman & Chief Executive Officer at TerSera Therapeutics LLC. He is also on the board of Illinois Biotechnology Industry Organization and Senseonics Holdings, Inc. He previously occupied the position of VP-Pharmaceutical Commercial Operations at Abbott Laboratories and President of Abbott Diabetes Care, Inc. (a subsidiary of Abbott Laboratories), Principal at Bristol Myers Squibb Co., Director & Executive Vice President at TAP Pharmaceutical Products, Inc., Chairman & Chief Executive Officer at Crealta Pharmaceuticals LLC and Chief Executive Officer of Actient Pharmaceuticals LLC. Mr. Fiorentino received an undergraduate degree from The State University of New York and an MBA from Syracuse University.